Автор: Hellwig K, Gold R.

Glatiramer acetate and interferon-beta throughout gestation and postpartum in women with multiple sclerosis.

J Neurol.

Автор: Fragoso YD, Finkelsztejn A, Kaimen-Maciel DR, Grzesiuk AK, Gallina AS, Lopes J, Morales NM, Alves-Leon SV, de Almeida SM.

Long-term use of glatiramer acetate by 11 pregnant women with multiple sclerosis: a retrospective, multicentre case series.

CNS Drugs.

Автор: Coyle PK, Christie S, Fodor P, Fuchs K, Giesser B, Gutierrez A, Lynn J, Weinstock-Guttman B, Pardo L; Women Neurologists MS Initiative.

Multiple sclerosis gender issues: clinical practices of women neurologists.

Mult Scler.

Автор: Ziemssen T, Neuhaus O, Hohlfeld R.

Risk-benefit assessment of glatiramer acetate in multiple sclerosis.

Drug Saf.

Автор: Krysko KM, Dobson R, Alroughani R, Amato MP, Bove R, Ciplea AI, Fragoso Y, Houtchens M, Jokubaitis VG, Magyari M, Abdelnasser A, Padma V, Thiel S, Tintore M, Vukusic S, Hellwig K.

Family planning considerations in people with multiple sclerosis.

Lancet Neurol. 2023 Apr;22(4):350-366.

Автор: Sánchez-Velasco S, Midaglia L, Vidal-Jordana A, Castillo F, Horno R, Carreras E, Serrano B, Bosch M, Agustí A, Montalban X, Tintoré M.

Fármacos modificadores de la enfermedad en la esclerosis múltiple durante la lactancia: revisión de la evidencia actual.

Rev Neurol. 2023 Jan 1;76(1):21-30.

Автор: Collorone S, Kodali S, Toosy AT.

The protective role of breastfeeding in multiple sclerosis: Latest evidence and practical considerations.

Front Neurol. 2023 Jan 24;13:1090133.

Автор: Langer-Gould AM.

Pregnancy and Family Planning in Multiple Sclerosis.

Continuum (Minneap Minn). 2019 Jun;25(3):773-792.

Автор: Almas S, Vance J, Baker T, Hale T.

Management of Multiple Sclerosis in the Breastfeeding Mother.

Mult Scler Int. 2016;2016:6527458.

Автор: Alroughani R, Altintas A, Al Jumah M, Sahraian M, Alsharoqi I, AlTahan A, Daif A, Dahdaleh M, Deleu D, Fernandez O, Grigoriadis N, Inshasi J, Karabudak R, Taha K, Totolyan N, Yamout BI, Zakaria M, Bohlega S.

Pregnancy and the Use of Disease-Modifying Therapies in Patients with Multiple Sclerosis: Benefits versus Risks.

Mult Scler Int.

Автор: Fragoso YD.

Glatiramer acetate to treat multiple sclerosis during pregnancy and lactation: a safety evaluation.

Expert Opin Drug Saf.

Автор: Cree BA.

Update on reproductive safety of current and emerging disease-modifying therapies for multiple sclerosis.

Mult Scler. 2013 Jun;19(7):835-43.

Автор: Fragoso YD, Boggild M, Macias-Islas MA, Carra A, Schaerer KD, Aguayo A, de Almeida SM, Alvarenga MP, Alvarenga RM, Alves-Leon SV, Arruda WO, Brooks JB, Comini-Frota ER, Ferreira ML, Finkelsztejn A, Finkelsztejn JM, de Freitas LD, Gallina AS, da Gama PD, Georgetto S, Giacomo MC, Gomes S, et al.

The effects of long-term exposure to disease-modifying drugs during pregnancy in multiple sclerosis.

Clin Neurol Neurosurg.

Автор: Hellwig K, Haghikia A, Rockhoff M, Gold R.

Multiple sclerosis and pregnancy: experience from a nationwide database in Germany.

Ther Adv Neurol Disord. 2012 Sep;5(5):247-53.